Adverse reactions related to hematopoietic stem cell infusion
暂无分享,去创建一个
[1] P. Vyas,et al. Cellular basis of hematopoiesis and stem cell transplantation , 2016 .
[2] K. Chan,et al. High white blood cell concentration in the peripheral blood stem cell product can induce seizures during infusion of autologous peripheral blood stem cells. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[3] S. Heimfeld,et al. Limiting the daily total nucleated cell dose of cryopreserved peripheral blood stem cell products for autologous transplantation improves infusion-related safety with no adverse impact on hematopoietic engraftment. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[4] J. Tisdale,et al. 5% Dimethyl sulfoxide (DMSO) and pentastarch improves cryopreservation of cord blood cells over 10% DMSO , 2010, Transfusion.
[5] E. C. Barbeta,et al. Adverse reactions during transfusion of thawed haematopoietic progenitor cells from apheresis are closely related to the number of granulocyte cells in the leukapheresis product , 2010, Vox sanguinis.
[6] G. C. Santis,et al. Criopreservação de células-progenitoras hematopoéticas , 2009 .
[7] B. Labar,et al. Toxicity related to autologous peripheral blood haematopoietic progenitor cell infusion is associated with number of granulocytes in graft, gender and diagnosis of multiple myeloma , 2008, Vox sanguinis.
[8] Ø. Bruserud,et al. Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation , 2008, Transfusion.
[9] F. Hernández-Navarro,et al. The occurrence of adverse events during the infusion of autologous peripheral blood stem cells is related to the number of granulocytes in the leukapheresis product , 2007, Bone Marrow Transplantation.
[10] V. Vanneaux,et al. Recovery, viability and clinical toxicity of thawed and washed haematopoietic progenitor cells: analysis of 952 autologous peripheral blood stem cell transplantations , 2007, Bone Marrow Transplantation.
[11] B. Esterni,et al. Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product , 2007, Transfusion.
[12] P. Quesenberry,et al. Cryopreservation of hematopoietic stem cells , 2007, American journal of hematology.
[13] K. Vossel,et al. Encephalopathy, stroke, and myocardial infarction with DMSO use in stem cell transplantation , 2007, Neurology.
[14] G. Saydam,et al. Clinical side effects during peripheral blood progenitor cell infusion. , 2007, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[15] D. Kadidlo,et al. Patient care during infusion of hematopoietic progenitor cells , 2004, Transfusion.
[16] C. Júnior,et al. Transplante de medula óssea e transplante de sangue de cordão umbilical em pediatria , 2001 .
[17] M. Czuczman,et al. Severe respiratory depression after dimethylsulphoxide-containing autologous stem cell infusion in a patient with AL amyloidosis , 2000, Bone Marrow Transplantation.